Synthesis and antiviral properties of aza-analogues of Acyclovir

Nucleosides, Nucleotides and Nucleic Acids

Volumn 26, Issue 1, 2007, Pages 51-64

  Koszytkowska Stawińska, Mariola ^a   Kaleta, Katarzyna ^a   Sas, Wojciech ^a   De Clercq, Erik ^b  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Acyclic nucleosides; Acyclovir analogues; Antiviral agents; Aza nucleosides

Indexed keywords

1 [N (2 PIVALOYLOXYETHYL) 4 TOLUENESULFONYLAMINOMETHYL] 5 METHYL 1H,3H PYRIMIDINE 2,4 DIONE; 2 AMINO 9 [N (2 PIVALOYLOXYETHYL) 4 TOLUENESULFONYLAMINOMETHYL] 9H PURIN 6 ONE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ACICLOVIR; ACICLOVIR DERIVATIVE; GANCICLOVIR; NUCLEOSIDE; RIBAVIRIN; TENOFOVIR; TOLUENESULFONAMIDE DERIVATIVE;

ALKYLATION; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CROSS COUPLING REACTION; DEPROTECTION REACTION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; ONE POT SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; SILYLATION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; HELA CELLS; HUMANS; NUCLEOSIDES; SULFONAMIDES; VERO CELLS; VIRUSES;

EID: 33845663475     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770601052281     Document Type: Article

References (52)

1. De Clercq, E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30, 115-133.
2. Galmarini, C.M.; Mackey, J.R.; Dumontet, C. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 2002, 3, 415-424.
3. De Clercq, E.; Field, H.J. Antiviral prodrugs-The development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol. 2006, 147, 1-11.
4. Selected papers published during last five years: (a) Gao, H.; Mitra, A.K. Regioselective synthesis of various prodrugs of ganciclovir. Tetrahedron Lett. 2000, 41, 1131-1136;
5. (b) Beadle, J.R.; Kini, G.D.; Aldern, K.A.; Gardner, M.F.; Wright, K.N.; Rybak, R.J.; Kern, E.R.; Hostetler, K.Y. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: Efficacy against HSV-1 infection in mice. Nucleosides, Nucleotides Nucleic Acids 2000, 19, 471-479;
6. (c) McGuigan, C.; Slater, M.J.; Parry, N.R.; Perry, A.; Harris, S. Synthesis and antiviral activity of acyclovir-5′-(phenylmethoxyalaninyl) phosphate as a possible membrane-soluble nucleotide prodrug. Bioorg. Med. Chem. Lett. 2000, 10, 645-647;
7. (d) Balzarini, J.; Haller-Meier, F., De Clercq, E.; Meier C. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir. Antiviral Chem. Chemother., 2001, 12, 301-306;
8. (e) Tak, R.V.; Pal, D.; Gao, H.; Dey, S.; Mitra, A.K. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J. Pharm. Sci. 2001, 90, 1505-1515;
9. (f) Gao, H.; Mitra, A.K. Regioselective synthesis of acyclovir and its various prodrugs. Synth. Commun. 2001, 31, 1399-1420;
10. (g) Yang, C.; Gao, H.; Mitra, A.K. Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir. J. Pharm. Sci. 2001, 90, 617-624;
11. (h) Dias, C.S.; Anand, B.S.; Mitra, A.K. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: Physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs. J. Pharm. Sci. 2002, 91, 660-668;
12. (i) Nashed, Y.E.; Mitra, A.K. Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir. Spectrochim. Acta A 2003, 59, 2033-2039;
13. (j) Salamonczyk, G.M. Acyclovir terminated thiophosphate dendrimers. Tetrahedron Lett. 2003, 44, 7449-7453.
14. El Ashry, E.S.H.; El Kilany, Y. Acyclonucleosides: Part 1. Seco-Nucleosides. Adv. Heterocycl. Chem. 1997, 67, 391-438,
15. Acyclonucleosides: Part 2. diseco-Nucleosides. Adv. Heterocycl. Chem. 1997, 68, 1-88;
16. Acyclonucleosides: Part 3. tri-, tetra-, and pentaseco-Nucleosides. Adv. Heterocycl. Chem. 1998, 69, 129-215;
17. (b) Simons, C. Nucleoside Mimetics: Their Chemistry and Biological Aspects. Gorgon and Breach Science Publishers: Amsterdam, 2001; pp. 161-172;
18. (c) Vorbrüggen, H.; Ruh-Pohlenz, C. Handbook of Nucleoside Synthesis. John Wiley: New York, 2001; Tables I-XI; pp. 110-589;
19. (d) Ichikawa, E.; Kato. K. Sugar-modified nucleosides in past 10 years, A review. Curr. Med. Chem. 2001, 8, 385-423;
20. (c) Jeong, L.S.; Lee, J.A. Recent advances in the synthesis of the carbocyclic nucleosides as potential antiviral agents. Antivir. Chem. Chemother. 2004, 15, 235-250;
21. (e) Kumar, R. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents. Curr. Med. Chem. 2004, 11, 2749-2766.
22. Montgomery, J.A.; Temple, C. Synthesis of potential anticancer agents. XXVI. The alkylation of 6-chloropurine. J. Am. Chem. Soc. 1961, 83, 630-635;
23. (b) Nishitani, T.; Horikawa, H.; Iwasaki, T.; Matsumoto, K.; Inoue, I.; Miyoshi, M. Synthetic electroorganic chemistry. 14. Synthesis of 5-fluorouracil derivatives having N-acylazacycloalkanes and lactams. J. Org. Chem. 1982, 47, 1706-1712;
24. (c) Sergeev, V.N.; Shapovalenko, E.P.; Baukov, Yu.I. Silyl method for the synthesis of N-(organosulfonamidomethyl)lactams and imides. Russ. J. Gen. Chem. (Engl. Transl.) 1987, 57, 1177-1182
25. [Zh. Obshch. Khim., 1987, 57, 1315-1321];
26. (d) Nishitani, T.; Iwasaki, T.; Mushika, Y.; Inoue, I.; Miyoshi, M. Synthesis of 3-amino-3-(5-fluorouracil-1-yl)propionic acid and 4-amino-4-(5-fluorouracil-1-yl)butyric acid derivatives. Chem. Pharm. Bull. 1980, 28, 1137-1141;
27. (e) Inoue, K.; Iwasaki, T.; Nishitani, T.; Kondou, K.; Arai, Y. 5-Fluorouracil derivative and its preparation. JP58216169, 1983 (Chem. Abstr. 1984, 100, 174851b);
28. (f) Miyoshi, S; Inoue, K.; Mushishika, Y.; Iwasaki T.; Nishitani, T.; Arai, Y. 5-Fluorouracil derivative and preparation thereof. JP58213762, 1983 (Chem. Abstr. 1984, 100, 174852c);
29. (g) Kingsbury, W.D.; Boehm, J.C.; Mehta, R.J.; Grappel, S.F.; Gilvarg, C. A novel peptide delivery system involving peptidase activated prodrugs as antimicrobial agents. Synthesis and biological activity of peptidyl derivatives of 5-fluorouracil. J. Med. Chem. 1984, 27, 1447-1451;
30. (h) Nichifor, M.; Schacht, E.H. Synthesis of peptide derivatives of 5-fluorouracil. Tetrahedron 1994, 50, 3747-3760;
31. Khutova, B.M.; Klyuchko, S.V.; Prikazchikova, L.P. Amidoalkylation of pyrimidine bases of nucleic acids. Chem. Heterocycl. Compd. (Engl. Transl.) 1991, 27, 407-409
32. [Khim. Geterotsikl. Soedin. 1991, 512-515];
33. (j) Besova, E.A.; Goloshchapov, N.M.; Goloshchapova, E.N.; Michurina, A. E.; Shipov, A. G.; Baukov, Yu.I. Reaction of Substituted 5-oxazolidinones with 2,4-bis(trimethylsiloxy)pyrimidines. Russ. J. Gen. Chem. (Engl. Transl.) 1998, 68, 469-471
34. [Zh. Obshch. Khim., 1998, 68, 502-504];
35. (k) Madec-Lougerstay, R.; Florent, J.-C.; Monneret, C. Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy. J. Chem. Soc., Perkin Trans. 1 1999, 1369-1376;
36. (l) Kita, Y; Shibata, N; Yoshida, N; Tohjo, T. An efficient synthesis of 4-heterofunction-substituted 3-(1-hydroxy)ethylazetidin-2-ones from 3-(1-hydroxy)ethyl-4-phenylsulfinylazetidin-2-one by reaction with silylated heteronucleophiles. Chem. Pharm. Bull. 1992, 40, 1733-1736;
37. (m) Gilchrist, T.L; Mendonca, R. Addition of pyrimidine and purine bases to benzyl 2H-azirine-3-carboxylate. Synlett 2000, 12, 1843-1845;
38. (n) Zheltonogova, E.A.; Oleneva, G.I.; Shapovalenko, E.P.; Belavin, I.Yu.; Shipov, A.G.; Baukov, Yu.I. Silyl variant of the amidoalkylation of 5-substituted uracils with 2-pyrrolidinone derivatives. Russ. J. Gen. Chem. (Engl. Transl.) 1990, 60, 1245-1249
39. [Zh. Obshch. Khim. 1990, 60, 1390-1394];
40. (o) Bergmeier, S.C.; Fundy, S.L.; Drach, J.C. Synthesis and antiviral activity of novel aza-acyclonucleosides. Nucleosides, Nucleotides Nucleic Acid 1999, 18, 227-238;
41. (p) Sheikha, G.A.; La Colla, P.; Loi, A.G. A new class of acyclic nucleoside phosphonates: synthesis and biological activity of 9-{[(phosphonomethyl)aziridin-1-yl]methyl}guanine (pmamg) and analogues. Nucleosides, Nucleotides Nucleic Acids 2002, 10, 619-635.
42. Koszytkowska-Stawinska, M.; Sas, W. Facile synthesis of acyclic azanucleosides from Npivaloyloxymethyl amides and sulfonamides: synthesis of aza-analogues of Ganciclovir. Tetrahedron Lett. 2004, 45, 5437-5440.
43. Augstein, J.; Austin, W.C.; Boscott, R.J.; Green, S.M.; Worting, C.R. Some Cardiovascular effects of a series of aryloxyalkylamines. I. J. Med. Chem. 1965, 8, 356-367.
44. Vorbrüggen, H.; Ruh-Pohlenz, C. Handbook of Nucleoside Synthesis. John Wiley: New York, 2001, pp. 29-33 and 110-140.
45. Robins, M.J.; Zou, R.; Hansske, F.; Madej, D.; Tyrrell, D.L.J. Synthesis, transformation chemistry, and biological activity of guanine nucleosides and analogues. Nucleosides, Nucleotides Nucleic Acids 1989, 8, 725-741.
46. (a) Zou, R.; Robins, M.J. High-yield regioselective synthesis of 9-glycosyl guanine nucleosides and analogues via coupling with 2-N-acetyl-6-O-diphenylcarbamoylguanine. Can. J. Chem. 1987, 65, 1436-1437;
47. (b) Robins, M.J.; Zou, R.; Guo, Z; Wnuk, S.F. Nucleic acid related compounds. 93. A solution for the historic problem of regioselective sugar-base coupling to produce 9-glycosylguanines or 7-glycosylguanines. J. Org. Chem. 1996, 61, 9207-9212;
48. (c) Tolle-Sander, S.; Lentz, K.A.; Maeda, D.Y.; Coop, A.; Polli, J. E. Increased acyclovir oral bioavailability via a bile acid conjugate. Mol. Pharm. 2004, 1, 40-48.
49. Žinić, B.; Krizmanić, I.; Vikić-Topić, D.; Žinić, M. 5-Bromo- and 5-iodo-N-1-sulfonylated cytosine derivatives. Exclusive formation of keto-imino tautomers. Croat. Chem. Acta 1999, 72, 957-966.
50. Marek, R.; Sklenar, V. NMR studies of purines. Annu. Rep. NMR Spectrosc. 2005, 54, 201-242.
51. Required to cause a microscopically detectable alteration of normal cell morphology.
52. 6SM cells, >100 μM).